Sorry, no definitions found. You may find more data at enhance.


Sorry, no etymologies found.


  • Perhaps we’ll see some Better Gmail integration in Enhance Gmail’s future.

    Integrate Gmail and Google Calendar with Enhance Gmail | Lifehacker Australia

  • The action by the government came after a study, called Enhance, raised questions about whether the drugs were more effective than generic drugs.

    Merck, Schering-Plough Reach Settlement Over Drug Marketing

  • Last fall critics charged that the companies were delaying disclosure of findings of a major Vytorin study called Enhance in order to protect sales.

    House Panel Seeks

  • And the study, known as Enhance, offers no clear signals that patients should stop using Vytorin.

    Cutting Through the Confusion Over Vytorin

  • The study, called Enhance, was completed in April 2006.

    Study Deals Setback to Cholesterol Drug

  • Deepak Khanna, general manager of the Merck Schering-Plough joint venture that markets the drugs, said the companies 'sales force has prepared a letter for doctors that provides the companies' view of the study presented at the conference and will provide copies of the study, called Enhance, to doctors.

    Schering, Merck

  • That study, called Enhance, fueled a backlash that resulted in plummeting prescriptions of Zetia and its sister drug Vytorin, which had combined sales in 2007 of $5.1 billion.

    Study Says Zetia May Help Fight Heart Disease

  • The panel made its recommendations on the basis of a 720-patient imaging study known as Enhance in which Vytorin failed to show a benefit over a cheaper generic drug in halting the progression of disease in neck arteries, a measure of heart-attack and stroke risk.

    Schering, Merck

  • Schering and Merck said Monday that results of the trial, called Enhance, showed that Vytorin failed to slow progression of heart disease more effectively than Zocor, a cholesterol drug known as a statin that is available in generic form at a far lower price.

    Study Missteps Threaten

  • Dr. Kastelein formally presented results of the study, called Enhance, Sunday at the annual meeting of the American College of Cardiology in Chicago.

    Merck and Schering Release


Log in or sign up to get involved in the conversation. It's quick and easy.